电邮这篇文章 Modern possibilities of drug treatment of uterine fibroids
- 作者: Aganezova N.V1
-
隶属关系:
- Mechnikov North-West State Medical University
- 期: 卷 65, 编号 3 (2016)
- 页面: 79-83
- 栏目: Articles
- URL: https://journals.rcsi.science/jowd/article/view/3544
- DOI: https://doi.org/10.17816/JOWD65379-83
- ID: 3544
如何引用文章
全文:
详细
Uterine fibroids is one of the most common gynecological diseases. Modern drug therapy of uterine fibroids can reduce or reverse the symptoms of a tumor, in some cases, to avoid surgery.
作者简介
Natalia Aganezova
Mechnikov North-West State Medical University
Email: aganezova@mail.ru
MD, Associate Professor, Department of Obstetrics and Gynecology
参考
- Yoshino O, et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod. 2010 Oct;25(10):2475-9. doi: 10.1093/humrep/deq222.
- Pez-Lopez FR, et al. EMAS position statement: management of uterine fibroids. Maturitas. 2014;79:106-116. doi: 10.1016/j.maturitas.2014.06.002.
- The FIGO classification of causes of abnormal uterine bleeding: Malcolm G. Munro, Hilary O.D. Crithcley, Ian S. Fraser, for the FIGO Working Group on Menstrual Disorders. Int J Gynaecol Obstet. 2011 Apr;113(1):1-2. doi: 10.1016/j.ijgo.2011.01.001.
- Kroon B, et al. Australasian CREI Consensus Expert Panel on Trial evidence (ACCEPT) group. Fibroids in infertility - consensus statement from ACCEPT (Australasian CREI Consensus Expert Panelon Trial evidence). Aust N Z J Obstet Gynaecol. 2011;51:289-95. doi: 10.1111/j.1479-828X.2011.01300.x.
- Downes E, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol. 2010 Sep;152(1):96-102. doi: 10.1016/j.ejogrb.2010.05.012.
- Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308:1589-92. doi: 10.1126/science.1112063
- Eder S, et al. Efficacy and safety oforal tranexamic acid in women with heavy menstrual bleeding and fibroids. Women’s Health (Lond, Engl). 2013;9:397-403. doi: 10.2217/whe.13.28.
- Naoulou B, Tsai MC. Efficacy of tranexamic acid in the treatment of idio-pathic and non-functional heavy menstrual bleeding: a systematic review. Acta Obstet Gynecol Scand. 2012;91:529-37. doi: 10.1111/j.1600-0412.2012.01361.x.
- Hoellen F, Griesinger G, Bohlmann MK. Therapeutic drugs in the treat-ment of symptomatic uterine fibroids. Expert Opin Pharmacother. 2013;14:2079-85. doi: 10.1517/14656566.2013.825607.
- Chiaffarino F, et al. Use of oral contraceptives and uterine fibroids: results from a case-control study. Br J Obstet Gynaecol. 1999 Aug;106(8):857-60. doi: 10.1111/j.1471-0528.1999.tb08409.x.
- Mueck AO, Seeger H, Rabe T. Hormonal contraception and risk of endometrial cancer: a systematic review. Endocr Relat Cancer. 2010 Sep 23;17(4):R263-71. doi: 10.1677/ERC-10-0076.
- Fauser BC, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and sterility. 2012;97:28-38. doi: 10.1016/j.fertnstert.2011.09.024.
- Sangkomkamhang US, Lumbiganon P, Laopaiboon M, Mol BW. Progestogensor progestogen-releasing intrauterine systems for uterine fibroids. Cochrane Database Syst Rev. 2013;2:CD008994.
- Depypere HT, et al. A 60-month non-comparative studyon bleeding profiles with the levonorgestrel intrauterine system from the latetransition period to estrogen supplemented menopause. Eur J Obstet Gynecol Reprod Biol. 2010;153:176-80. doi: 10.1016/j.ejogrb.2010.08.017.
- Moroni R, et al. Pharmacological treatment of uterine fibroids. Ann Med Health Sci Res. 2014 Sep;4 (Suppl 3): S185-92. doi: 10.4103/2141-9248.141955.
- Donnez J, et al. Ulipristal acetate versus leuprolideacetate for uterine fibroids. N Engl J Med. 2012;366:421-32. doi: 10.1056/NEJMoa1103180.
- Donnez J, et al. Long-term treatment of uterinefibroids with ulipristal acetate. Fertil Steril. 2014;101:1565-73. doi: 10.1016/j.fertnstert.2014.02.008.
补充文件
